摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

SN56 | 1272483-42-7

中文名称
——
中文别名
——
英文名称
SN56
英文别名
3-(2-(azepan-1-yl)ethyl)-4-bromo-6-propylbenzo[d]thiazol-2(3H)-one hydrochloride
SN56化学式
CAS
1272483-42-7
化学式
C18H25BrN2OS*ClH
mdl
——
分子量
433.84
InChiKey
ADNOPNXZTXIYIF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.08
  • 重原子数:
    24.0
  • 可旋转键数:
    5.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.61
  • 拓扑面积:
    25.24
  • 氢给体数:
    0.0
  • 氢受体数:
    4.0

反应信息

  • 作为反应物:
    描述:
    SN56tritium 作用下, 生成 [(3)H]-SN56
    参考文献:
    名称:
    Synthesis and characterization of [3H]-SN56, a novel radioligand for the σ1 receptor
    摘要:
    The study of the binding characteristics of a ligands in vivo and in vitro requires radiolabeled probes with high affinity and selectivity. The radioligand presently used for in vitro studies of the sigma(1) receptor, [H-3](+)-pentazocine, has significant limitations; it is difficult to synthesize, has limited chemical stability, and can be problematic to obtain. Evaluation of a series of novel 2(3H)-benzothiazolone compounds revealed SN56 to have sub-nanomolar and preferential affinity for the sigma(1) subtype, relative to sigma(2) and non-sigma, binding sites. The goal of this study was to characterize the binding of [H-3]-SN56 to sigma(1) receptors isolated from rat brain. Standard in vitro binding techniques were utilized to 1) determine the specificity and affinity of binding to sigma(1) receptors, 2) confirm that [H-3]-SN56 labels sites previously identified as sigma(1) by comparing binding to sites labeled by [H-3](+)-pentazocine, and 3) characterize the kinetics of binding. The results indicate that [H-3]-SN56 exhibits 1) specific, saturable, and reversible binding to the sigma(1) receptor, with B-max = 340 +/- 10 fmol/mg and K-d = 0.069 +/- 0.0074 nM, 2) competitive displacement by classical sigma compounds, yielding sigma K-1(i) values consistent with those reported in the literature, and 3) binding kinetics compatible with a 90 mm incubation, and filtration for separation of free and bound radioligand. The results of these studies suggest that [H-3]-SN56 may serve as a viable alternative to [H-3](+)-pentazocine in radioligand binding assays. (C) 2010 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.ejphar.2010.10.099
  • 作为产物:
    描述:
    6-丙基-1,3-苯并噻唑-2-醇碳酸氢钠溶剂黄146 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 16.0h, 生成 SN56
    参考文献:
    名称:
    Synthesis and characterization of [3H]-SN56, a novel radioligand for the σ1 receptor
    摘要:
    The study of the binding characteristics of a ligands in vivo and in vitro requires radiolabeled probes with high affinity and selectivity. The radioligand presently used for in vitro studies of the sigma(1) receptor, [H-3](+)-pentazocine, has significant limitations; it is difficult to synthesize, has limited chemical stability, and can be problematic to obtain. Evaluation of a series of novel 2(3H)-benzothiazolone compounds revealed SN56 to have sub-nanomolar and preferential affinity for the sigma(1) subtype, relative to sigma(2) and non-sigma, binding sites. The goal of this study was to characterize the binding of [H-3]-SN56 to sigma(1) receptors isolated from rat brain. Standard in vitro binding techniques were utilized to 1) determine the specificity and affinity of binding to sigma(1) receptors, 2) confirm that [H-3]-SN56 labels sites previously identified as sigma(1) by comparing binding to sites labeled by [H-3](+)-pentazocine, and 3) characterize the kinetics of binding. The results indicate that [H-3]-SN56 exhibits 1) specific, saturable, and reversible binding to the sigma(1) receptor, with B-max = 340 +/- 10 fmol/mg and K-d = 0.069 +/- 0.0074 nM, 2) competitive displacement by classical sigma compounds, yielding sigma K-1(i) values consistent with those reported in the literature, and 3) binding kinetics compatible with a 90 mm incubation, and filtration for separation of free and bound radioligand. The results of these studies suggest that [H-3]-SN56 may serve as a viable alternative to [H-3](+)-pentazocine in radioligand binding assays. (C) 2010 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.ejphar.2010.10.099
点击查看最新优质反应信息

同类化合物

噻吩并[3,2-d]异噻唑-5-羧酸乙酯 5-苯基-3-(1H-吡唑-1-基)噻吩并[2,3-d]异噻唑1,1-二氧化 4-氯-8-(甲基硫烷基)异噻唑并[4',5':4,5]噻吩并[3,2-d][1,2,3]三嗪 4-氨基-3-甲硫基噻吩并[4,5-d][1,2]噻唑-5-甲酰胺 4-氨基-3-甲基噻吩并[2,3-c]异噻唑-5-羧酸乙酯 4-氨基-3-[(4-氟苯甲基)硫烷基]噻吩并[2,3-c]异噻唑-5-甲酰胺 4-[2-(6-甲氧基萘-2-基)丙基]-N-甲基哌嗪-1-甲酰胺 4,6-二氢噻吩并[3,4-d][1,3]噻唑5,5-二氧化物 3-甲基噻吩并[2,3-c]异噻唑-5-羧酸乙酯 3-(4-氯-3,5-二甲基-1H-吡唑-1-基)噻吩并[3,4-d]异噻唑1,1-二氧化 3-(4-氯-1H-吡唑-1-基)噻吩并[3,4-d]异噻唑1,1-二氧化 3-(3,5-二甲基吡唑-1-基)噻吩并[3,4-d][1,2]噻唑1,1-二氧化物 2-甲基噻吩并噻唑 2-甲基噻吩并[2,3-d]异噻唑-3(2H)-酮 1,1-二氧化物 2-氨基噻吩并[2,3-d]噻唑-6-羧酸 甲酯 2-氨基噻吩并[2,3-D]噻唑 1,1-二氧代噻吩并[2,3-D]异噻唑-3-酮 (9CI)-2-氨基-噻吩并[2,3-d]噻唑-5-羧酸 2-[[1-Oxo-2-[6-(trifluoromethyl)pyridin-3-yl]-1,2-thiazolidin-1-ylidene]amino]-1,3-thiazol-4-one 6-cyano-2-ethyl-5-(trimethylsilyl)thieno[2,3-b]pyridine methyl 5-(1-methoxy-2-methylpropyl)-2,2'-bisthiazole-4-carboxylate 5-(2-methylpropen-1-yl)-2,2'-bisthiazole-4-carboxylic acid N-tert-Butyl-S-(4-chloro-isothiazolo[4,5-d]isothiazol-3-yl)-thiohydroxylamine ethyl 2-oxo-5-chloro-6-phenyl-3-benzothiazolineacetate 2-Hydroxy-5-phenylthieno<2,3-d>thiazol 1,1-dioxo-5-phenyl-1λ6-[1,4,2]dithiazinane-3-thione 1,1-dioxo-5-p-tolyl-1λ6-[1,4,2]dithiazinane-3-thione 5-phenyl-thieno[2,3-d]thiazol-2-ylamine 4-amino-1λ6,2-thiazinane-1,1-dione hydrochloride 4-(2,2-dioxo-2,3,3a,9a-tetrahydro-1H-2λ6-benzo[b]thieno[3,4-e][1,4]thiazin-9-yl)-butylamine 3-Propyl-4,6-dihydro-thieno[3,4-d]isothiazole 5,5-dioxide 4,5-dichloro-N-[3-(2-chloro-6-fluorophenyl)-1,2,4-thiadiazol-5-yl]thiophene-2-sulfonamide ethyl 6-N-formylaminothieno<2,3-d>thiazole-5-carboxylate 3,5-dichloro-thieno[3,2-b]thiophene-2-carboxylic acid 3-morpholin-4-yl-propylamide 7-acetyl-3,4,8-triamino-1H-pyrazolo<3,4-d>thieno<2,3-b>pyridin Methyl2-aminothieno[2,3-d][1,3]thiazole-5-carboxylatehydrochloride (3aR,6aR)-3-Benzyl-5,5-dioxo-hexahydro-5λ6-thieno[3,4-d]thiazol-2-ylideneamine; hydrobromide ethyl 3,5-dimethylthieno[3,2-c]diazepine-1-carboxylate 3,5-dimethyl-2-(4-methyl-thiazol-2-ylmethyl)-2H-[1,2]thiazine 1,1-dioxide 3-Methylthio-7-amino-isothiazolo<3',4':2,3>thieno<2,3-c>pyrimidin 13-Isobutyl-5.11-imino-5H.11H-dipyrido<2.3-b:2'.3'-f><1.5>dithiocin K-(4-Amino-3-methylthio-thieno<2,3-c>isothiazol-5)-carboxylat SN56 ethyl 4-amino-3-methylthiothieno<3,2-d>isothiazole-5-carboxylate 3-methyl-4-(3-methyl-5-phenylthiophen-2-yl)-4H-pyrimidine;hydrochloride 2-(Dimethylamino)thieno[2,3-d][1,3]thiazole-5-carboxylic acid 7-Bromothieno[3,2-c]pyridine-2-carboxylic acid 2,3-Dihydro-2-methyl-3-thioxo-thieno<3,4-d>isothiazol-1,1-dioxid